Pulmonary involvement in systemic sclerosis due to therapy and as a complication

https://doi.org/10.4081/monaldi.2005.648

Authors

  • F. Chiappini | fabrizio.chiappini@fastwebnet.it Divisione di Pneumologia, Università Cattolica del Sacro Cuore, Roma, Italy.
  • A. Zoli Divisione di Reumatologia,, Università Cattolica del Sacro Cuore, Roma, Italy.
  • L. Maugeri Divisione di Pneumologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Abstract

(SS), similar to other connective tissue diseases. Sometimes lung disease may be a side effect of antirheumathic drugs. We report a case of a patient affected by SS, with isolated pulmonary hypertension, who developed bronchiolitis secondary to penicillamine. The latter was treated by withdraw of the drug without increasing the steroids. After one month, the patient’s clinical conditions appeared improved.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2005-06-30
Info
Issue
Section
Case Reports
Keywords:
Systemic sclerosis, bronchiolitis, penicillamine, pulmonary hypertension
Statistics
  • Abstract views: 267

  • PDF: 278
How to Cite
Chiappini, F., A. Zoli, and L. Maugeri. 2005. “Pulmonary Involvement in Systemic Sclerosis Due to Therapy and As a Complication”. Monaldi Archives for Chest Disease 63 (2). https://doi.org/10.4081/monaldi.2005.648.

Similar Articles

You may also start an advanced similarity search for this article.